Recombinant IL20 (Fletikumab Biosimilar) antibody

Catalog No. ABIN7675771

The Human Monoclonal anti-IL20 (Fletikumab Biosimilar) antibody (ABIN7675771) specifically detects IL20 (Fletikumab Biosimilar) in FACS, BLI, ELISA, Func and SPR. The antibody is reactive with Human samples.

Quick Overview for Recombinant IL20 (Fletikumab Biosimilar) antibody (ABIN7675771)

Target: IL20 (Fletikumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This IL20 (Fletikumab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), ELISA, Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-IL20 (Fletikumab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-IL-20 Reference Antibody (fletikumab)

Characteristics: Anti-IL-20 Reference Antibody (fletikumab) is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG4 S228P

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for IL20 (Fletikumab Biosimilar)

Target: IL20 (Fletikumab Biosimilar)

Alternative Name: IL-20 (Fletikumab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: Q9NYY1